Download PDF
Exp Clin Endocrinol Diabetes 2020; 128(11): 723-730
DOI: 10.1055/a-0992-9114
Article

Association between Biomarkers of Low-grade Inflammation and Sex Hormones in Women with Polycystic Ovary Syndrome

Erifili Hatziagelaki
1   Second Department of Internal Medicine, Research Institute and Diabetes Center, “Attikon” University Hospital, National and Kapodistrian University of Athens, Athens, Greece
,
Vasilios Pergialiotis
2   Third Department of Obstetrics and Gynecology, “Attikon” University Hospital, National and Kapodistrian University of Athens, Athens, Greece
,
Julia M. Kannenberg
3   Institute for Clinical Diabetology, German Diabetes Center, Leibniz Center for Diabetes Research at Heinrich Heine University Düsseldorf, Düsseldorf, Germany
4   German Center for Diabetes Research (DZD), Partner Düsseldorf, Germany
,
Eftihios Trakakis
2   Third Department of Obstetrics and Gynecology, “Attikon” University Hospital, National and Kapodistrian University of Athens, Athens, Greece
,
Anastasia Tsiavou
1   Second Department of Internal Medicine, Research Institute and Diabetes Center, “Attikon” University Hospital, National and Kapodistrian University of Athens, Athens, Greece
,
Daniel F. Markgraf
3   Institute for Clinical Diabetology, German Diabetes Center, Leibniz Center for Diabetes Research at Heinrich Heine University Düsseldorf, Düsseldorf, Germany
4   German Center for Diabetes Research (DZD), Partner Düsseldorf, Germany
,
Maren Carstensen-Kirberg
3   Institute for Clinical Diabetology, German Diabetes Center, Leibniz Center for Diabetes Research at Heinrich Heine University Düsseldorf, Düsseldorf, Germany
4   German Center for Diabetes Research (DZD), Partner Düsseldorf, Germany
,
Giovanni Pacini
5   Metabolic Unit, CNR Neuroscience Institute, National Research Council, Padova, Italy
,
Michael Roden
3   Institute for Clinical Diabetology, German Diabetes Center, Leibniz Center for Diabetes Research at Heinrich Heine University Düsseldorf, Düsseldorf, Germany
4   German Center for Diabetes Research (DZD), Partner Düsseldorf, Germany
6   Division of Endocrinology and Diabetology, Medical Faculty, Heinrich Heine University Düsseldorf, Düsseldorf, Germany
,
George Dimitriadis
1   Second Department of Internal Medicine, Research Institute and Diabetes Center, “Attikon” University Hospital, National and Kapodistrian University of Athens, Athens, Greece
,
Christian Herder
3   Institute for Clinical Diabetology, German Diabetes Center, Leibniz Center for Diabetes Research at Heinrich Heine University Düsseldorf, Düsseldorf, Germany
4   German Center for Diabetes Research (DZD), Partner Düsseldorf, Germany
6   Division of Endocrinology and Diabetology, Medical Faculty, Heinrich Heine University Düsseldorf, Düsseldorf, Germany
› Author Affiliations
› Further Information
Also available at
    Permissions and Reprints

Abstract

Objective Women with polycystic ovary syndrome (PCOS) have higher circulating levels of C-reactive protein, but the relationship between inflammation and endocrine function in PCOS remains poorly understood. Thus, this study aimed to investigate the association between low-grade inflammation and sex hormones in women with PCOS.

Design and Patients A comprehensive panel of biomarkers of inflammation was measured in serum of 63 women with PCOS using proximity extension assay technology. Associations of 65 biomarkers with sex hormones were assessed without and with adjustment for age and body mass index (BMI).

Results In the unadjusted analysis, 20 biomarkers were positively correlated with 17-OH-progesterone (17-OH-P), 14 with prolactin and 6 with free testosterone, whereas inverse associations were found for 16 biomarkers with sex hormone-binding globulin (SHBG), 6 with luteinizing hormone (LH) and 6 with estrogen (all p<0.05). Among the positive associations, correlations were mainly found for five chemokines (CXCL11, CCL4, MCP-4/CCL13, CXCL5, CXCL6) and for VEGF-A, LAP-TGFβ1, TNFSF14 and MMP-1. Inverse associations with sex hormones were mainly present for two chemokines (CXCL1, MCP-2/CCL8), CDCP1, CST5 and CSF-1. Adjustment for age and BMI reduced the number of biomarker associations for SHBG and estrogen, but had hardly any impact on associations with 17-OH-P, prolactin, free testosterone and LH.

Conclusion Women with PCOS feature BMI-independent associations between biomarkers of inflammation and certain sex steroid and hypophyseal hormones. Most of these inflammation-related biomarkers were chemokines, which may be relevant as potential mediators of the increased cardiometabolic risk of women with PCOS.

Key words

inflammation - chemokines - sex hormones - polycystic ovary syndrome - cardiometabolic risk

Supplementary Material



Publication History

Received: 18 October 2018
Received: 25 July 2019

Accepted: 07 August 2019

Article published online:
28 August 2019

© 2020. Thieme. All rights reserved.

Georg Thieme Verlag KG
Rüdigerstraße 14, 70469 Stuttgart, Germany

 

  • References

  • 1 Ding T, Hardiman PJ, Petersen I. et al. The prevalence of polycystic ovary syndrome in reproductive-aged women of different ethnicity: A systematic review and meta-analysis. Oncotarget 2017; 8: 96351-96358
    Google Scholar
  • 2 Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. Fertil Steril 2004; 81: 19-25
    CrossrefPubMedGoogle Scholar
  • 3 Chang RJ. The reproductive phenotype in polycystic ovary syndrome. Nat Clin Pract Endocrinol Metab 2007; 3: 688-695
    CrossrefPubMedGoogle Scholar
  • 4 Teede HJ, Misso ML, Costello MF. et al. International PCOS Network. Recommendations from the international evidence-based guideline for the assessment and management of polycystic ovary syndrome. Fertil Steril 2018; 110: 364-379
    CrossrefPubMedGoogle Scholar
  • 5 Ding EL, Song Y, Malik VS. et al. Sex differences of endogenous sex hormones and risk of type 2 diabetes: A systematic review and meta-analysis. JAMA 2006; 295: 1288-1299
    CrossrefPubMedGoogle Scholar
  • 6 Ding EL, Song Y, Manson JE. et al. Plasma sex steroid hormones and risk of developing type 2 diabetes in women: A prospective study. Diabetologia 2007; 50: 2076-2084
    CrossrefPubMedGoogle Scholar
  • 7 Zhao D, Guallar E, Ouyang P. et al. Endogenous sex hormones and incident cardiovascular disease in post-menopausal women. J Am Coll Cardiol 2018; 71: 2555-2566
    CrossrefPubMedGoogle Scholar
  • 8 Subramanya V, Zhao D, Ouyang P. et al. Association of endogenous sex hormone levels with coronary artery calcium progression among post-menopausal women in the Multi-Ethnic Study of Atherosclerosis (MESA). J Cardiovasc Comput Tomogr 2019; 13: 41-47
    CrossrefPubMedGoogle Scholar
  • 9 Gilbert EW, Tay CT, Hiam DS. et al. Comorbidities and complications of polycystic ovary syndrome: An overview of systematic reviews. Clin Endocrinol (Oxf) 2018; 89: 683-699
    CrossrefPubMedGoogle Scholar
  • 10 Glintborg D, Rubin KH, Nybo M. et al. Cardiovascular disease in a nationwide population of Danish women with polycystic ovary syndrome. Cardiovasc Diabetol 2018; 17: 37
    CrossrefPubMedGoogle Scholar
  • 11 Anagnostis P, Tarlatzis BC, Kauffman RP. Polycystic ovarian syndrome (PCOS): Long-term metabolic consequences. Metabolism 2018; 86: 33-43
    CrossrefPubMedGoogle Scholar
  • 12 Norman RJ, Dewailly D, Legro RS. et al. Polycystic ovary syndrome. Lancet 2007; 370: 685-697
    CrossrefPubMedGoogle Scholar
  • 13 Sathyapalan T, Atkin SL. Mediators of inflammation in polycystic ovary syndrome in relation to adiposity. Mediators Inflamm 2010; 2010: 758656
    CrossrefPubMedGoogle Scholar
  • 14 Repaci A, Gambineri A, Pasquali R. The role of low-grade inflammation in the polycystic ovary syndrome. Mol Cell Endocrinol 2011; 335: 30-41
    CrossrefPubMedGoogle Scholar
  • 15 Skurk T, Alberti-Huber C, Herder C. et al. Relationship between adipocyte size and adipokine expression and secretion. J Clin Endocrinol Metab 2007; 92: 1023-1033
    CrossrefPubMedGoogle Scholar
  • 16 Herder C, Dalmas E, Boni-Schnetzler M. et al. The IL-1 pathway in type 2 diabetes and cardiovascular complications. Trends Endocrinol Metab 2015; 26: 551-563
    CrossrefPubMedGoogle Scholar
  • 17 Herder C, Kannenberg JM, Huth C. et al. Proinflammatory cytokines predict the incidence and progression of distal sensorimotor polyneuropathy: KORA F4/FF4 Study. Diabetes Care 2017; 40: 569-576
    CrossrefPubMedGoogle Scholar
  • 18 Koliaki C, Szendroedi J, Kaul K. et al. Adaptation of hepatic mitochondrial function in humans with non-alcoholic fatty liver is lost in steatohepatitis. Cell Metab 2015; 21: 739-746
    CrossrefPubMedGoogle Scholar
  • 19 Frasca D, Blomberg BB, Paganelli R. Aging, obesity, and inflammatory age-related diseases. Front Immunol 2017; 8: 1745
    CrossrefPubMedGoogle Scholar
  • 20 Herder C, de Las Heras Gala T, Carstensen-Kirberg M. et al. Circulating levels of interleukin 1-receptor antagonist and risk of cardiovascular disease: Meta-analysis of six population-based cohorts. Arterioscler Thromb Vasc Biol 2017; 37: 1222-1227
    CrossrefPubMedGoogle Scholar
  • 21 Wu H, Yu K, Yang Z. Associations between TNF-alpha and interleukin gene polymorphisms with polycystic ovary syndrome risk: A systematic review and meta-analysis. J Assist Reprod Genet 2015; 32: 625-634
    CrossrefPubMedGoogle Scholar
  • 22 de Alencar JB, Alves HV, Elpidio LN. et al. Polymorphisms of cytokine genes and polycystic ovary syndrome: A review. Metab Syndr Relat Disord 2016; 14: 468-474
    CrossrefPubMedGoogle Scholar
  • 23 González F. Inflammation in polycystic ovary syndrome: Underpinning of insulin resistance and ovarian dysfunction. Steroids 2012; 77: 300-305
    CrossrefPubMedGoogle Scholar
  • 24 Lind L, Arnlov J, Lindahl B. et al. Use of a proximity extension assay proteomics chip to discover new biomarkers for human atherosclerosis. Atherosclerosis 2015; 242: 205-210
    CrossrefPubMedGoogle Scholar
  • 25 Nowak C, Sundstrom J, Gustafsson S. et al. Protein biomarkers for insulin resistance and type 2 diabetes risk in two large community cohorts. Diabetes 2016; 65: 276-284
    CrossrefPubMedGoogle Scholar
  • 26 Herder C, Kannenberg JM, Carstensen-Kirberg M. et al. A systemic inflammatory signature reflecting cross talk between innate and adaptive immunity is associated with incident polyneuropathy: KORA F4/FF4 Study. Diabetes 2018; 67: 2434-2442
    CrossrefPubMedGoogle Scholar
  • 27 Nowak C, Carlsson AC, Östgren CJ. et al. Multiplex proteomics for prediction of major cardiovascular events in type 2 diabetes. Diabetologia 2018; 61: 1748-1757
    CrossrefPubMedGoogle Scholar
  • 28 Rotterdam ESHRE/ASRM-Sponsored PCOS consensus workshop group. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS). Hum Reprod 2004; 19: 41-47
    CrossrefPubMedGoogle Scholar
  • 29 Schlesinger S, Herder C, Kannenberg JM. et al. General and abdominal obesity and incident distal sensorimotor polyneuropathy: Insights into inflammatory biomarkers as potential mediators in the KORA F4/FF4 cohort. Diabetes Care 2019; 42: 240-247
    CrossrefPubMedGoogle Scholar
  • 30 Enroth S, Enroth SB, Johansson A. et al. Protein profiling reveals consequences of lifestyle choices on predicted biological aging. Sci Rep 2015; 5: 17282
    CrossrefPubMedGoogle Scholar
  • 31 Enroth S, Johansson A, Enroth SB. et al. Strong effects of genetic and lifestyle factors on biomarker variation and use of personalized cutoffs. Nat Commun 2014; 5: 4684
    CrossrefPubMedGoogle Scholar
  • 32 Kodama S, Horikawa C, Fujihara K. et al. Comparisons of the strength of associations with future type 2 diabetes risk among anthropometric obesity indicators, including waist-to-height ratio: A meta-analysis. Am J Epidemiol 2012; 176: 959-969
    CrossrefPubMedGoogle Scholar
  • 33 Glintborg D, Andersen M. An update on the pathogenesis, inflammation, and metabolism in hirsutism and polycystic ovary syndrome. Gynecol Endocrinol 2010; 26: 281-296
    CrossrefPubMedGoogle Scholar
  • 34 Escobar-Morreale HF, Luque-Ramírez M, González F. Circulating inflammatory markers in polycystic ovary syndrome: A systematic review and metaanalysis. Fertil Steril 2011; 95: 1048-1058
    CrossrefPubMedGoogle Scholar
  • 35 Peng Z, Sun Y, Lv X. et al. Interleukin-6 levels in women with polycystic ovary syndrome: A systematic review and meta-analysis. PLoS One 2016; 11: e0148531
    CrossrefPubMedGoogle Scholar
  • 36 González F, Rote NS, Minium J. et al. Evidence of proatherogenic inflammation in polycystic ovary syndrome. Metabolism 2009; 58: 954-962
    CrossrefPubMedGoogle Scholar
  • 37 Atabekoglu CS, Sönmezer M, Özmen B. et al. Increased monocyte chemoattractant protein-1 levels indicating early vascular damage in lean young PCOS patients. Fertil Steril 2011; 95: 295-297
    CrossrefPubMedGoogle Scholar
  • 38 Hu W, Qiao J, Yang Y. et al. Elevated C-reactive protein and monocyte chemoattractant protein-1 in patients with polycystic ovary syndrome. Eur J Obstet Gynecol Reprod Biol 2011; 157: 53-56
    CrossrefPubMedGoogle Scholar
  • 39 Waltenberger J, Lange J, Kranz A. Vascular endothelial growth factor-A-induced chemotaxis of monocytes is attenuated in patients with diabetes mellitus: A potential predictor for the individual capacity to develop collaterals. Circulation 2000; 102: 185-190
    CrossrefPubMedGoogle Scholar
  • 40 Miyazono K, Olofsson A, Colosetti P. et al. A role of the latent TGF-beta 1-binding protein in the assembly and secretion of TGF-beta 1. EMBO J 1991; 10: 1091-1101
    CrossrefPubMedGoogle Scholar
  • 41 Shaikh RB, Santee S, Granger SW. et al. Constitutive expression of LIGHT on T cells leads to lymphocyte activation, inflammation, and tissue destruction. J Immunol 2001; 167: 6330-6337
    CrossrefPubMedGoogle Scholar
  • 42 Wortmann A, He Y, Deryugina EI. et al. The cell surface glycoprotein CDCP1 in cancer—Insights, opportunities, and challenges. IUBMB Life 2009; 61: 723-730
    CrossrefPubMedGoogle Scholar
  • 43 Ferrer-Mayorga G, Alvarez-Diaz S, Valle N. et al. Cystatin D locates in the nucleus at sites of active transcription and modulates gene and protein expression. J Biol Chem 2015; 290: 26533-26548
    CrossrefPubMedGoogle Scholar
  • 44 Hume DA, MacDonald KP. Therapeutic applications of macrophage colony-stimulating factor-1 (CSF-1) and antagonists of CSF-1 receptor (CSF-1R) signaling. Blood 2012; 119: 1810-1820
    CrossrefPubMedGoogle Scholar
  • 45 Ojeda-Ojeda M, Murri M, Insenser M. et al. Mediators of low-grade chronic inflammation in polycystic ovary syndrome (PCOS). Curr Pharm Des 2013; 19: 5775-5791
    CrossrefPubMedGoogle Scholar
  • 46 Shorakae S, Teede H, de Courten B. et al. The emerging role of chronic low-grade inflammation in the pathophysiology of polycystic ovary syndrome. Semin Reprod Med 2015; 33: 257-269
    Article in Thieme ConnectPubMedGoogle Scholar
  • 47 Herder C, Baumert J, Thorand B. et al. Chemokines as risk factors for type 2 diabetes: Results from the MONICA/KORA Augsburg study, 1984-2002. Diabetologia 2006; 49: 921-929
    CrossrefPubMedGoogle Scholar
  • 48 Herder C, Baumert J, Thorand B. et al. Chemokines and incident coronary heart disease: Results from the MONICA/KORA Augsburg case-cohort study, 1984–2002. Arterioscler Thromb Vasc Biol 2006; 26: 2147-2152
    CrossrefPubMedGoogle Scholar
  • 49 van der Vorst EP, Döring Y, Weber C. Chemokines. Arterioscler Thromb Vasc Biol 2015; 35: e52-e56
    CrossrefPubMedGoogle Scholar
  • 50 Dusi V, Ghidoni A, Ravera A. et al. Chemokines and heart disease: A network connecting cardiovascular biology to immune and autonomic nervous systems. Mediators Inflamm 2016; 2016: 5902947
    CrossrefPubMedGoogle Scholar
  • 51 Marchetti P. Islet inflammation in type 2 diabetes. Diabetologia 2016; 59: 668-672
    CrossrefPubMedGoogle Scholar
  • 52 Rudemiller NP, Crowley SD. The role of chemokines in hypertension and consequent target organ damage. Pharmacol Res 2017; 119: 404-411
    CrossrefPubMedGoogle Scholar
  • 53 Chang TT, Chen JW. Emerging role of chemokine CC motif ligand 4 related mechanisms in diabetes mellitus and cardiovascular disease: Friends or foes?. Cardiovasc Diabetol 2016; 15: 117
    CrossrefPubMedGoogle Scholar
  • 54 Yang Z, Zhang Z, Wen J. et al. Elevated serum chemokine CXC ligand 5 levels are associated with hypercholesterolemia but not a worsening of insulin resistance in Chinese people. J Clin Endocrinol Metab 2010; 95: 3926-3932
    CrossrefPubMedGoogle Scholar
  • 55 Van Dyke AL, Lang Kuhs KA, Shiels MS. et al. Associations between self-reported diabetes and 78 circulating markers of inflammation, immunity, and metabolism among adults in the United States. PLoS One 2017; 12: e0182359
    CrossrefPubMedGoogle Scholar
  • 56 Choi SH, Ruggiero D, Sorice R. et al. Six novel loci associated with circulating VEGF levels identified by a meta-analysis of genome-wide association studies. PLoS Genet 2016; 12: e1005874
    CrossrefPubMedGoogle Scholar
  • 57 Halvorsen B, Santilli F, Scholz H. et al. LIGHT/TNFSF14 is increased in patients with type 2 diabetes mellitus and promotes islet cell dysfunction and endothelial cell inflammation in vitro. Diabetologia 2016; 59: 2134-2144
    CrossrefPubMedGoogle Scholar